GGrantIndex
← Leaderboards

Angela L Slitt

University Of Kansas Medical Center

$7,634,782
Attributed
$7,899,229
Total exposure
15
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,899,229 · 15

By mechanism

P42$3,088,388 · 5
R01$2,782,261 · 2
P20$834,807 · 4
R15$439,285 · 1
R43$352,596 · 1
K22$322,848 · 1

Top collaborators

Most similar at University Of Kansas Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Liver

Research focus

LiverIn VivoExposure ToAffectPropertyGene ExpressionProteinsToxic EffectHepaticSourceUptakeCellsBloodDietMediatingExcretory FunctionAntioxidantsProgramsSerumHepatocyteRegulationPharmaceutical PreparationsGenesEnvironmental Exposure

Grant awards (33)

Pharmacology Core$464,538
P20 · FY2025 · GM · contact PI
The role of albumin and other serum factors in Per- and polyfluoroalkyl substance (PFAS) accumulation and toxicity$385,219
R01 · FY2025 · ES · contact PI
Mechanisms of Exposure$159,973
P42 · FY2025 · ES · contact PI
Research Experience and Training Coordination Core (RETCC)$54,110
P42 · FY2025 · ES · contact PI
Mechanisms of Exposure$348,369
P42 · FY2024 · ES · contact PI
Research Experience and Training Coordination Core (RETCC)$79,789
P42 · FY2024 · ES · contact PI
Mechanisms of Exposure$218,314
P42 · FY2023 · ES · contact PI
Research Experience and Training Coordination Core (RETCC)$79,626
P42 · FY2023 · ES · contact PI
Mechanisms of Exposure$268,461
P42 · FY2022 · ES · contact PI
Research Experience and Training Coordination Core (RETCC)$99,819
P42 · FY2022 · ES · contact PI
Sources, Transport, Exposure and Effects of PFASs (STEEP)$296,431
P42 · FY2021 · ES · contact PI
Sources, Transport, Exposure and Effects of PFASs (STEEP)$281,167
P42 · FY2020 · ES · contact PI
Sources, Transport, Exposure and Effects of PFASs (STEEP)$302,472
P42 · FY2019 · ES · contact PI
Sources, Transport, Exposure and Effects of PFASs (STEEP)$288,842
P42 · FY2019 · ES · contact PI
Sources, Transport, Exposure and Effects of PFASs (STEEP)$308,580
P42 · FY2018 · ES · contact PI
Sources, Transport, Exposure and Effects of PFASs (STEEP)$302,435
P42 · FY2017 · ES · contact PI
Developmental exposure to Bisphenol A and susceptibility to liver injury$439,285
R15 · FY2015 · ES · contact PI
Effect of nutritional status on MRP2 expression and biliary excretion of bispheno$361,672
R01 · FY2012 · ES · contact PI
Effect of nutritional status on MRP2 expression and biliary excretion of bispheno$361,672
R01 · FY2011 · ES · contact PI
Treatment of stroke using a novel PDZ binding peptidomimetic drug.$352,596
R43 · FY2011 · NS
Effect of nutritional status on MRP2 expression and biliary excretion of bispheno$355,749
R01 · FY2010 · ES · contact PI
Effect of nutritional status on MRP2 expression and biliary excretion of bispheno$485,226
R01 · FY2009 · ES · contact PI
Effect of nutritional status on MRP2 expression and biliary excretion of bispheno$236,235
R01 · FY2009 · ES · contact PI
Effect of nutritional status on MRP2 expression and biliary excretion of bispheno$118,711
R01 · FY2009 · ES · contact PI
Role of Nrf2 during cholestsis and gallstone formation$107,616
K22 · FY2009 · ES · contact PI
RESVERATROL INDUCTION OF GENE EXPRESSION VIA ACTIVATION OF CAR AND NRF2$97,139
P20 · FY2009 · RR · contact PI
Effect of nutritional status on MRP2 expression and biliary excretion of bispheno$477,777
R01 · FY2008 · ES · contact PI
RESVERATROL INDUCTION OF GENE EXPRESSION VIA ACTIVATION OF CAR AND NRF2$124,428
P20 · FY2008 · RR · contact PI
Role of Nrf2 during cholestsis and gallstone formation$107,616
K22 · FY2008 · ES · contact PI
RESVERATROL INDUCTION OF GENE EXPRESSION VIA ACTIVATION OF CAR AND NRF2$148,702
P20 · FY2007 · RR · contact PI
Role of Nrf2 during cholestsis and gallstone formation$107,616
K22 · FY2007 · ES · contact PI
Mechanism of altered vectoral hepatic excretion$44,212
F32 · FY2002 · ES
Mechanism of altered vectoral hepatic excretion$34,832
F32 · FY2001 · ES